Prostate cancer: open trials in Mexico

12 open trials have a site in Mexico. Registry data; only the trial team decides who can take part.

NCT06136624
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
CIO - Centro de Inmuno-Oncología de Occidente ( Site 1103), Guadalajara · Medical Care and Research SA de CV ( Site 1108), Mérida · Centro de Investigacion Clinica de Oaxaca ( Site 1109), Mexico City · Quemex Medical and Research ( Site 1112), Mexico City · Filios Alta Medicina ( Site 1106), Monterrey · Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 1107), Monterrey
Registry updated 2026-11-05
NCT06925737
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0541), Guadalajara · Higiea Oncologia ( Site 0542), Mexico City · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran ( Site 0545), Mexico City · Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" ( Site 0540), Monterrey · Centro de Investigacion Clinica de Oaxaca ( Site 0543), Oaxaca City · Grupo Ollin Care ( Site 0544), Pachuca
Registry updated 2026-10-30
NCT04557449
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Trial Treatment · Phase 1/2 · Pfizer
INCAN, Mexico City · Hospital MAC Periferico Sur, Mexico City · COI Centro Oncologico Internacional S.A.P.I. de C.V., Mexico City · Hospital Universitario Dr. Jose Eleuterio González, Monterrey · Hospital Reforma, Oaxaca City · Oaxaca Site Management Organization, Oaxaca City
Registry updated 2026-10-28
NCT05939414
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Huxquilucan · Mexico City
Registry updated 2026-10-21
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0928), Guadalajara · Health Pharma Professional Research S.A. de C.V: ( Site 0929), Mexico City · Higiea Oncologia ( Site 0938), Mexico City · Centro de Investigacion Clinica de Oaxaca ( Site 0934), Mexico City · Filios Alta Medicina ( Site 0931), Monterrey · Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0932), Monterrey · Eukarya Pharmasite S.C. ( Site 0939), Monterrey · Quemex Medical and Research ( Site 0937), Tlalpan
Registry updated 2026-10-20
NCT06855277
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Mexico City
Registry updated 2026-10-15
NCT07206056
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Tlalpan
Registry updated 2026-10-09
NCT03678025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Trial Treatment · Phase 3 · SWOG Cancer Research Network
Instituto Nacional De Cancerologia de Mexico, Mexico City
Registry updated 2026-10-08
NCT07287150
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
Trial Treatment · Phase 2 · Hoffmann-La Roche
Productos y Servicios Oncologicos Acacias SA de CV, Benito Juárez · Hospital MAC León, León · Health Pharma Professional Research S.A. de C.V., Mexico City
Registry updated 2026-10-08
NCT06780670
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Trial Treatment · Phase 2/3 · Novartis Pharmaceuticals
Huxquilucan · Mexico City
Registry updated 2026-09-22
NCT07225309
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Trial Treatment · Memorial Sloan Kettering Cancer Center
Instituto Nacional de Cancerología (INCan), Mexico City
Registry updated 2026-08-03
NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Trial Treatment · Phase 3 · Canadian Cancer Trials Group
Instituto Nacional De Cancerologia de Mexico, Mexico City
Registry updated 2026-07-14

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error